Tianli Pharmaceutical's VC deep-processing project achieves profits

On 28 Jan., 2015, Shandong Tianli Pharmaceutical Co., Ltd. (Tianli Pharmaceutical) disclosed that the revenue from VC deep-processing products was USD6.79 million (RMB41.66 million) in 2014. It has produced 1,747 tonnes of VC phosphate, 1,368 tonnes ...

Vitamins China E-News 201502

www.cnchemicals.com